RF9 acts as a KISS1R agonist in vivo and in vitro

SILVIA LEON TELLEZLEONOR PINILLA JURADOMANUEL JOSE TENA SEMPERE2026-01-292026-01-29201510.1210/en.2015-16352-s2.0-84948134436https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/26596EndocrinologyEndocrinologyRF9 acts as a KISS1R agonist in vivo and in vitroresearch article